Delivery Order SPE2DB24D2011-SPE2DB25FBRTT
- Not listed
- The Defense Logistics Agency awarded a $1,698.21 delivery order to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count units) on September 9, 2025, with completion targeted for September 10, 2025. This non-competitive, firm fixed-price delivery order was executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,320.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The order has an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,882.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules, valued at $1,046.72. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,376.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This contract utilizes a firm fixed-price structure and is not set aside for any particular business category. The award is classified as a delivery order, indicating it derives from an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,434.93 to AmerisourceBergen Drug Corp for 1,000 units of Duloxetine HCL DR 60 mg capsules, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (90-count) with a ceiling value of $2,267.82. The contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded delivery order under firm fixed pricing. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,659.63 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 60 mg, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued on August 29, 2025, was not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRTTDelivery Order
The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This is a non-set-aside award with a completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime contractor supporting the military and veteran healthcare supply chain through the Defense Logistics Agency's Medical Supply Chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contractor's capacity to fulfill this order demonstrates its established capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/8/25 |